JP2009531036A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009531036A5 JP2009531036A5 JP2009501824A JP2009501824A JP2009531036A5 JP 2009531036 A5 JP2009531036 A5 JP 2009531036A5 JP 2009501824 A JP2009501824 A JP 2009501824A JP 2009501824 A JP2009501824 A JP 2009501824A JP 2009531036 A5 JP2009531036 A5 JP 2009531036A5
- Authority
- JP
- Japan
- Prior art keywords
- vegf receptor
- domain
- kdr
- receptor fusion
- flt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100662572A CN100502945C (zh) | 2006-03-31 | 2006-03-31 | Vegf受体融合蛋白在治疗眼睛疾病中的应用 |
| PCT/CN2007/001021 WO2007112675A1 (fr) | 2006-03-31 | 2007-03-29 | Protéine de fusion du récepteur du vegf et son utilisation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009531036A JP2009531036A (ja) | 2009-09-03 |
| JP2009531036A5 true JP2009531036A5 (cg-RX-API-DMAC7.html) | 2009-12-17 |
Family
ID=37736587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009501824A Pending JP2009531036A (ja) | 2006-03-31 | 2007-03-29 | Vegf受容体融合タンパク質およびそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090264358A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2000483A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009531036A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090010030A (cg-RX-API-DMAC7.html) |
| CN (1) | CN100502945C (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007234272A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0710223A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2647142A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2008136655A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007112675A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3142945A1 (en) | 2005-03-25 | 2006-10-05 | Regeneron Pharmaceuticals, Inc. | Histidine-buffered formulations of vegf antagonist |
| CA2654510C (en) | 2006-06-16 | 2015-03-17 | Regeneron Pharmaceuticals, Inc. | Vegf antagonist formulations suitable for intravitreal administration |
| CN101279092B (zh) * | 2007-04-02 | 2010-10-27 | 成都康弘生物科技有限公司 | Vegf受体融合蛋白在制备治疗与血管生成有关的疾病中的应用 |
| CN101721699B (zh) * | 2008-10-13 | 2012-11-07 | 成都康弘生物科技有限公司 | Vegf受体融合蛋白在制备治疗伴随vegf升高的炎症反应的药物中的应用 |
| KR101248912B1 (ko) * | 2009-12-31 | 2013-03-29 | 한양대학교 산학협력단 | 항혈관신생 활성을 가지는 재조합 아데노바이러스 |
| CN102233132B (zh) * | 2010-04-28 | 2013-10-23 | 成都康弘生物科技有限公司 | Vegf受体融合蛋白在制备抑制眼表新生血管生长的药物中的应用 |
| CN103816115B (zh) * | 2010-08-31 | 2017-06-27 | 成都康弘生物科技有限公司 | 一种含有抑制血管增生的融合蛋白的药物组合物及用途 |
| CN102380096B (zh) * | 2010-08-31 | 2014-04-30 | 成都康弘生物科技有限公司 | 一种含有抑制血管增生的融合蛋白的药物组合物及用途 |
| KR20180023015A (ko) | 2011-01-13 | 2018-03-06 | 리제너론 파아마슈티컬스, 인크. | 혈관신생 눈 장애를 치료하기 위한 vegf 길항제의 용도 |
| KR102049990B1 (ko) | 2013-03-28 | 2019-12-03 | 삼성전자주식회사 | c-Met 항체 및 VEGF 결합 단편이 연결된 융합 단백질 |
| WO2015200905A2 (en) | 2014-06-28 | 2015-12-30 | Oligasis, Llc | Dual pdgf/vegf antagonists |
| JP6631865B2 (ja) * | 2014-08-11 | 2020-01-15 | 日本化薬株式会社 | TGFβ阻害機能を持つキメラタンパク質 |
| CN106999511A (zh) | 2014-12-11 | 2017-08-01 | 拜耳医药保健有限责任公司 | 具有小的活动性脉络膜新生血管病变的年龄相关性黄斑变性的治疗 |
| WO2017046140A1 (en) | 2015-09-18 | 2017-03-23 | Bayer Pharma Aktiengesellschaft | Treatment regimens for dr and rvo in dependence of the extent of retinal ischemia |
| KR20200093621A (ko) | 2017-11-30 | 2020-08-05 | 리제너론 파아마슈티컬스, 인크. | 혈관형성 눈 장애를 치료하기 위한 vegf 길항제의 용도 |
| CA3092588A1 (en) | 2018-03-02 | 2019-09-06 | Kodiak Sciences Inc. | Il-6 antibodies and fusion constructs and conjugates thereof |
| RS67656B1 (sr) | 2018-05-10 | 2026-02-27 | Regeneron Pharma | Formulacije koje sadrže visoke koncentracije fuzionog proteina vegf receptora |
| BR112021003275A2 (pt) | 2018-12-07 | 2021-06-22 | Remegen Co., Ltd. | inibidor de angiogênese bifuncional e uso do mesmo |
| PE20240329A1 (es) | 2019-06-05 | 2024-02-27 | Regeneron Pharma | Dispositivos y metodos para administracion de dosis de precision |
| CN115335529B (zh) * | 2019-11-26 | 2026-07-03 | 马萨诸塞大学 | 用于递送kh902(康柏西普)的重组腺相关病毒及其用途 |
| IL309560B2 (en) | 2019-12-06 | 2025-05-01 | Regeneron Pharma | Anti-VEGF protein preparations and methods for their production |
| MX2022013812A (es) | 2020-05-08 | 2022-12-15 | Regeneron Pharma | Trampas y mini-trampas de vegf y metodos para el tratamiento de trastornos oculares y cancer. |
| FI4185318T3 (fi) | 2021-05-17 | 2025-10-13 | Regeneron Pharma | Pitkäaikaisia, suuren annoksen VEGF-antagonistihoitoja angiogeenisten silmäsairauksien hoitoon |
| US12649031B2 (en) | 2021-09-08 | 2026-06-09 | Regeneron Pharmaceuticals, Inc. | Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation |
| TW202400214A (zh) | 2022-03-15 | 2024-01-01 | 美商再生元醫藥公司 | 用於血管新生眼睛病症之治療之延長高劑量vegf拮抗劑方案 |
| US20230295266A1 (en) | 2022-03-15 | 2023-09-21 | Regeneron Pharmaceuticals, Inc. | Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye Disorders |
| EP4588469A4 (en) | 2022-09-16 | 2026-03-04 | Qilu Pharmaceutical Co Ltd | STABLE, HIGH-CONCENTRATION, SPONTANEOUSLY BUFFERING PHARMACEUTICAL COMPOSITION |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| CN121712520A (zh) | 2023-06-23 | 2026-03-20 | 瑞泽恩制药公司 | 用于治疗血管生成性眼病的延长的高剂量vegf拮抗剂方案 |
| CN120204358A (zh) * | 2023-12-27 | 2025-06-27 | 成都康弘生物科技有限公司 | 一种含有抗vegf的融合蛋白的药物组合物 |
| WO2025217334A1 (en) | 2024-04-09 | 2025-10-16 | Regeneron Pharmaceuticals, Inc. | Low concentration vegf receptor fusion protein containing formulations |
| CN118108862B (zh) * | 2024-04-29 | 2024-08-09 | 上海鼎新基因科技有限公司 | 抗血管新生的融合蛋白及其应用 |
| KR20260096819A (ko) | 2024-12-13 | 2026-06-24 | 리제너론 파아마슈티컬스, 인크. | 망막 정맥 폐쇄에 속발하는 혈관신생 눈 장애의 치료를 위한 연장된 고용량 vegf 길항제 레지먼 |
| WO2026148214A1 (en) | 2025-01-02 | 2026-07-09 | Regeneron Pharmaceuticals, Inc. | High concentration vegf receptor fusion protein containing buffer free formulations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101433715B (zh) * | 1999-06-08 | 2013-04-17 | 里珍纳龙药品有限公司 | 具有改善的药物动力学特性的修饰嵌合多肽 |
| US7087411B2 (en) * | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| AU2004273619A1 (en) * | 2003-09-23 | 2005-03-31 | Novartis Ag | Combinations of a VEGF receptor inhibitor with other therapeutic agents |
| CN1304427C (zh) * | 2004-06-08 | 2007-03-14 | 成都康弘生物科技有限公司 | 抑制血管新生的融合蛋白质及其用途 |
| ES2381014T3 (es) * | 2004-06-08 | 2012-05-22 | Chengdu Kanghong Biotechnologies Co., Ltd. | Proteína quimérica inhibidora de la angiogénesis y el uso |
-
2006
- 2006-03-31 CN CNB2006100662572A patent/CN100502945C/zh not_active Expired - Lifetime
-
2007
- 2007-03-29 BR BRPI0710223-2A patent/BRPI0710223A2/pt not_active IP Right Cessation
- 2007-03-29 CA CA002647142A patent/CA2647142A1/en not_active Abandoned
- 2007-03-29 WO PCT/CN2007/001021 patent/WO2007112675A1/zh not_active Ceased
- 2007-03-29 EP EP07720595A patent/EP2000483A4/en not_active Withdrawn
- 2007-03-29 RU RU2008136655/13A patent/RU2008136655A/ru not_active Application Discontinuation
- 2007-03-29 JP JP2009501824A patent/JP2009531036A/ja active Pending
- 2007-03-29 AU AU2007234272A patent/AU2007234272A1/en not_active Abandoned
- 2007-03-29 KR KR1020087025464A patent/KR20090010030A/ko not_active Withdrawn
-
2008
- 2008-09-29 US US12/241,017 patent/US20090264358A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008136655A (ru) | Гибридные белки рецептора vegf, их фармацевтические композиции и терапевтическое применение при заболеваниях глаз | |
| JP6334061B2 (ja) | 腫瘍血管遮断剤であるポリペプチド、遺伝子、発現ベクター、腫瘍血管遮断剤の組成物、及び腫瘍血管遮断剤であるポリペプチドの調製方法 | |
| KR101884616B1 (ko) | 유착 치료 또는 예방용 폴리펩티드 | |
| NO336021B1 (no) | Anvendelse av en antagonist av Angptl3 til fremstilling av et medikament for behandling eller forebygging av vevsskade forbundet med en inflammatorisk leversykdom, og en antagonist av Angptl3 for nevnte anvendelse. | |
| JP7405345B2 (ja) | 間葉系幹細胞の動員活性を有するペプチド | |
| RU2012148887A (ru) | Варианты дезинтегрина и их фармацевтическое применение | |
| CN110087666B (zh) | 用于治疗糖尿病、高血压和高胆固醇血症的组合物和方法 | |
| CN101605555A (zh) | 用于治疗伤口的基于TGF-β单体的药物和蛋白质 | |
| KR20200078425A (ko) | 재조합 변형된 섬유아세포 성장 인자 및 이의 치료적 용도 | |
| CN114466859B (zh) | 一种用于血管新生、淋巴管新生相关疾病的多肽及其用途 | |
| US10709757B2 (en) | Pharmaceutical composition for anti-angiogenesis containing cyclic pentadepsipeptide as an effective ingredient | |
| JP7672636B2 (ja) | 間葉系幹細胞の動員活性を有するペプチド | |
| WO2010129284A1 (en) | Inhibition of hair follicle growth by the wnt inhibitor dkk1 | |
| CN113755580A (zh) | 一种治疗和/或缓解淋巴水肿的药物干预靶点及其应用 | |
| JP2014512369A5 (cg-RX-API-DMAC7.html) | ||
| CN115057917B (zh) | 一种神经保护活性多肽及其应用 | |
| CN113846098B (zh) | 一种小rna及其在心血管疾病治疗中的用途 | |
| WO2012013110A1 (zh) | 具有抑制血管生成活性的多肽 | |
| CN110669143B (zh) | 一种短肽及其应用 | |
| CN1935838A (zh) | 胸腺素β4衍生物及其应用 | |
| CN116239701B (zh) | 一种融合蛋白及其应用 | |
| CN104288764A (zh) | Cd146作为预防和/或治疗缺血性眼部疾病的药物靶点的应用 | |
| CN106474113B (zh) | 一种用于缺血性脑卒中后神经再生的药物组合物及其应用 | |
| EP2772498B1 (en) | Polypeptides inhibiting neovascularization and uses thereof | |
| TWI445543B (zh) | 一種用以治療眼部脈絡膜血管新生之醫藥組合物 |